Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 2 hours 14 min ago

Verona Pharma share positive ensifentrine results in COPD

06/08/2019
The trial consisted of 37 patients with moderate-to-severe COPD, who received a single dose of either the drug or a placebo.

Tecentriq, chemo combo shows bladder cancer promise

06/08/2019
Tecentriq was the first cancer immunotherapy approved in bladder cancer.

Rivipansel flunks Phase III sickle cell trial

06/08/2019
The trial was for patients six and older with the disease who required treatment with IV opioids for occlusive crisis.

New blood test ‘highly accurate’ at early Alzheimer’s identification

06/08/2019
The test can measure levels of the Alzheimer’s protein amyloid beta in the blood.

Emgality ‘CONQUER’s in late-stage migraine trial

06/08/2019
Treatment with Emgality reduced monthly migraine headache days by 4.1 days.

Dupixent hits endpoints in paediatric trial

06/08/2019
33% of patients who received Dupixent every four weeks achieved clear or almost clear skin.

The Sales Awards Chair explains what makes the 2019 competition so beneficial & rewarding

06/08/2019
The Chair of the 2019 Sales Awards, David Garmon-Jones, shares his thoughts on what makes this competition such an exciting and worthwhile experience.

Flu vaccine could reduce risk of death for elderly patients

05/08/2019
For those who were vaccinated the risk of suffering a stroke was 16% lower than those who weren’t.

Turalio becomes first FDA-approved treatment for tenosynovial giant cell tumour

05/08/2019
GCT is a rare tumour that affects the synovium and tendon sheaths.

AZ’ Forxiga label updated in EU for type II diabetes

05/08/2019
The decision comes from positive cardiovascular (CV) outcomes and renal data from the Phase III DECLARE-TIMI 58 trial.

Sosei Heptares, Takeda embark on strategic R&D partnership

05/08/2019
The collaboration will combine Sosei’s structure-based drug design capabilities with Takeda’s discovery, development and therapeutic area expertise.

New PM pledges £1.8bn to NHS

05/08/2019
The 20 hospitals set to be upgraded at a cost of £850 million have been announced.

A broad range of companies have committed to the 2019 Communications Team of the Year competition

05/08/2019
With the entries for the 2019 competition well underway, PharmaTimes have seen a large number of industry leading companies putting their best teams and individuals forward.

FDA grants Opdivo combo Breakthrough Designation for melanoma

02/08/2019
Bempegaldesleukin, Nektar's lead immuno-oncology candidate, is an investigational CD122-preferential IL-2 pathway agonist.

Nucala receives self-administration EU approval

02/08/2019
It is the only monthly anti-IL5 biologic approved in Europe that patients can take home.

Aspirin should be offered to Lynch syndrome patients

02/08/2019
Patients with Lynch syndrome have an increased risk of colorectal cancer.

NICE backs Bayer’s Xarelto

02/08/2019
The decision is based on evidence from the COMPASS study, which was stopped early after meeting its primary efficacy endpoint.

NHS Confederation addresses new PM over ‘unfinished business’

01/08/2019
The NHS Confederation has penned a letter to Boris Johnson, the UK’s new prime minister.

E-theraputics, Novo Nordisk extend research collaboration

01/08/2019
The amendment extends the original contract by six months to June 2020.

GSK completes transaction with Pfizer

01/08/2019
GSK has a controlling equity interest of 68% and Pfizer has an equity interest of 32% in the venture.

Pages

X